Lymphoma Large-cell Anaplastic
📧 Sign up to get email alerts when something new happens for Lymphoma Large-cell Anaplastic.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas [Phase 1]
Phase 1 clinical trial evaluating T cells expressing a fully-human anti-CD30 CAR for CD30-expressing lymphomas; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL) [Phase 2]
Phase 2 clinical trial update on Brentuximab Vedotin in Chinese participants with relapsed/refractory CD30-positive Hodgkin lymphoma or syst…
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113) [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of brigatinib (AP26113) in lympho…